semaglutide and crohn's disease GLP-1 Use in Disease: Safety & IBD Considerations – PlexusDx Semaglutide & Crohn's Disease: Safety

Viel et al., 2021)

GLP-1 medications significantly slow gastric emptying the rate at which food and anything you swallow moves through your stomach

In the real world, however, most individuals do not have legal access to afamelanotide for cosmetic use, and both peptides, when obtained online, share the same fundamental problem: uncertain identity, purity, and dose

Mazza waived concerns that investors have missed out on the rally, noting the weight loss drug industry is still in its "early days." "The marketplace has plenty of room for growth with other companies coming in, whether they're with more powerful drugs or with things that actually you don't need to have an injectable." He also sees GLP-1 drugmakers following a similar trajectory to AI-linked stocks

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2 [5] (Garvey et al., Lancet , 2023))